Worth Financial Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $653K | Buy |
1,611
+8
| +0.5% | +$3.25K | 0.4% | 60 |
|
|
2025
Q1 | $798K | Buy |
1,603
+1,185
| +283% | +$590K | 0.51% | 48 |
|
|
2024
Q4 | $217K | Sell |
418
-49
| -10% | -$25.5K | 0.13% | 147 |
|
|
2024
Q3 | $289K | Sell |
467
-77
| -14% | -$47.6K | 0.17% | 126 |
|
|
2024
Q2 | $301K | Buy |
544
+19
| +4% | +$10.5K | 0.2% | 111 |
|
|
2024
Q1 | $305K | Buy |
525
+70
| +15% | +$40.7K | 0.21% | 106 |
|
|
2023
Q4 | $242K | Buy |
455
+1
| +0.2% | +$531 | 0.19% | 116 |
|
|
2023
Q3 | $230K | Buy |
454
+54
| +14% | +$27.3K | 0.21% | 110 |
|
|
2023
Q2 | $209K | Sell |
400
-82
| -17% | -$42.8K | 0.19% | 114 |
|
|
2023
Q1 | $278K | Buy |
482
+80
| +20% | +$46.1K | 0.27% | 90 |
|
|
2022
Q4 | $221K | Buy |
+402
| New | +$221K | 0.26% | 96 |
|